The role of endocrine hormones in regulating glucose homeostasis in the context of POLG-driven mitochondrial impairment and stress will be insightful to identify therapeutic targets for mitochondrial disease patients. This evidence concerns the gene POLG and inborn mitochondrial metabolism disorder.